Mantle Cell Lymphomas
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab in Patients Failing to Respond to or Relapsing After CAR T Cell Therapy for Relapsed or Refractory Lymphomas (NCT02650999) | Abramson Cancer Center at Penn Medicine | 2016-01-01 |
| Significance of Duration of Maintenance Therapy With Rituximab in Non-Hodgkin Lymphomas (NCT00877214) | Jurgen Barth | 2009-04-01 |
Track Mantle Cell Lymphomas automatically
Every clearance here is in the API, with alerts when new ones post.